Drug Trial Radar · NCT03823040
Clinical Assessment of Oxiconazole Nitrate Solid Lipid Nanoparticles Loaded Gel
Last checked: Nov 20, 2026Latest source record: Jan 30, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
28
Actual
Start
Jul 16, 2018
Primary completion
Dec 23, 2018
Study completion Dec 30, 2018
Sponsor
- Lead sponsor
- Minia UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 30, 2019
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 12 years, up to 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Clinical study for the developed oxiconazole nitrate solid lipid nanoparticles (SLNs) gel system compared to the corresponding marketed product was conducted on 28 patients with different types of tinea fungal infection.
Conditions
- Tinea
Interventions
Oxiconazole Nitrate Cream 1%Drug
Tinox® group was treated with oxiconazole nitrate cream 1 % . Treatment was performed by rubbing the cream twice daily for two/ four weeks according to different types of tinea.
Oxiconazole nitrate SLNs loaded gel.Drug
Oxiconazole nitrate SLNs loaded gel group was treated with oxiconazole nitrate SLNs loaded gel.Treatment was performed by rubbing the gel twice daily for two/ four weeks according to different types of tinea.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Measurement of clinical improvement using quartile grading scale patient satisfactionTime frame: one month
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Minia University Hospital,dermatology department, out patient clinic
Minya, Egypt
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.